Tumor protein translationally controlled 1 is a p53 target gene that promotes cell survival

References

• Brioudes F, Thierry AM, Chambrier P, Mollereau B, Bendahmane M. Translationally controlled tumor protein is a conserved mitotic growth integrator in animals and plants. Proc Natl Acad Sci USA 2010; 107:16384 - 9; http://dx.doi.org/10.1073/pnas.1007926107; PMID: 20736351
   PubMed Web of Science ®Google Scholar
• Sanchez JC, Schaller D, Ravier F, Golaz O, Jaccoud S, Belet M, et al. Translationally controlled tumor protein: a protein identified in several nontumoral cells including erythrocytes. Electrophoresis 1997; 18:150 - 5; http://dx.doi.org/10.1002/elps.1150180127; PMID: 9059837
   PubMed Web of Science ®Google Scholar
• Chen SH, Wu PS, Chou CH, Yan YT, Liu H, Weng SY, et al. A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner. Mol Biol Cell 2007; 18:2525 - 32; http://dx.doi.org/10.1091/mbc.E07-02-0188; PMID: 17475776
   PubMed Web of Science ®Google Scholar
• Gachet Y, Tournier S, Lee M, Lazaris-Karatzas A, Poulton T, Bommer UA. The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci 1999; 112:1257 - 71; PMID: 10085260
   PubMed Web of Science ®Google Scholar
• Kim M, Jung Y, Lee K, Kim C. Identification of the calcium binding sites in translationally controlled tumor protein. Arch Pharm Res 2000; 23:633 - 6; http://dx.doi.org/10.1007/BF02975253; PMID: 11156187
   PubMed Web of Science ®Google Scholar
• Demidenko ZN, Korotchkina LG, Gudkov AV, Blagosklonny MV. Paradoxical suppression of cellular senescence by p53. Proc Natl Acad Sci USA 2010; 107:9660 - 4; http://dx.doi.org/10.1073/pnas.1002298107; PMID: 20457898
   PubMed Web of Science ®Google Scholar
• Johansson H, Vizlin-Hodzic D, Simonsson T, Simonsson S. Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells. Cell Cycle 2010; 9:2160 - 9; http://dx.doi.org/10.4161/cc.9.11.11841; PMID: 20505363
   PubMed Web of Science ®Google Scholar
• Gnanasekar M, Dakshinamoorthy G, Ramaswamy K. Translationally controlled tumor protein is a novel heat shock protein with chaperone-like activity. Biochem Biophys Res Commun 2009; 386:333 - 7; http://dx.doi.org/10.1016/j.bbrc.2009.06.028; PMID: 19523440
   PubMed Web of Science ®Google Scholar
• Lucibello M, Gambacurta A, Zonfrillo M, Pierimarchi P, Serafino A, Rasi G, et al. TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. Exp Cell Res 2011; 317:2479 - 89; http://dx.doi.org/10.1016/j.yexcr.2011.07.012; PMID: 21801721
   PubMed Web of Science ®Google Scholar
• Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K. Gene silencing of translationally controlled tumor protein (TCTP) by siRNA inhibits cell growth and induces apoptosis of human prostate cancer cells. Int J Oncol 2009; 34:1241 - 6; PMID: 19360337
   PubMed Web of Science ®Google Scholar
• Liu H, Peng HW, Cheng YS, Yuan HS, Yang-Yen HF. Stabilization and enhancement of the antiapoptotic activity of mcl-1 by TCTP. Mol Cell Biol 2005; 25:3117 - 26; http://dx.doi.org/10.1128/MCB.25.8.3117-3126.2005; PMID: 15798198
   PubMed Web of Science ®Google Scholar
• Ma Q, Geng Y, Xu W, Wu Y, He F, Shu W, et al. The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells. J Proteome Res 2010; 9:40 - 9; http://dx.doi.org/10.1021/pr9001367; PMID: 19621893
   PubMed Web of Science ®Google Scholar
• Telerman A, Amson R. The molecular programme of tumour reversion: the steps beyond malignant transformation. Nat Rev Cancer 2009; 9:206 - 16; http://dx.doi.org/10.1038/nrc2589; PMID: 19180095
   PubMed Web of Science ®Google Scholar
• Tuynder M, Fiucci G, Prieur S, Lespagnol A, Géant A, Beaucourt S, et al. Translationally controlled tumor protein is a target of tumor reversion. Proc Natl Acad Sci USA 2004; 101:15364 - 9; http://dx.doi.org/10.1073/pnas.0406776101; PMID: 15489264
   PubMed Web of Science ®Google Scholar
• Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, et al. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1. Proc Natl Acad Sci USA 2002; 99:14976 - 81; http://dx.doi.org/10.1073/pnas.222470799; PMID: 12399545
   PubMed Web of Science ®Google Scholar
• Li F, Zhang D, Fujise K. Characterization of fortilin, a novel antiapoptotic protein. J Biol Chem 2001; 276:47542 - 9; http://dx.doi.org/10.1074/jbc.M108954200; PMID: 11598139
   PubMed Web of Science ®Google Scholar
• Chen W, Sun Z, Wang XJ, Jiang T, Huang Z, Fang D, et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol Cell 2009; 34:663 - 73; http://dx.doi.org/10.1016/j.molcel.2009.04.029; PMID: 19560419
   PubMed Web of Science ®Google Scholar
• Rotblat B, Melino G, Knight RA. NRF2 and p53: Januses in cancer?. Oncotarget 2012; 3:1272 - 83; PMID: 23174755
   PubMed Web of Science ®Google Scholar
• Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, et al. Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. Cancer Res 2009; 69:219 - 26; http://dx.doi.org/10.1158/0008-5472.CAN-08-2320; PMID: 19118006
   PubMed Web of Science ®Google Scholar
• Zhang Y, Qian Y, Lu W, Chen X. The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress. Cancer Res 2009; 69:6049 - 56; http://dx.doi.org/10.1158/0008-5472.CAN-09-0621; PMID: 19602589
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shu L, Chen X. Syntaxin 6, a regulator of the protein trafficking machinery and a target of the p53 family, is required for cell adhesion and survival. J Biol Chem 2008; 283:30689 - 98; http://dx.doi.org/10.1074/jbc.M801711200; PMID: 18779328
   PubMed Web of Science ®Google Scholar
• Feng X, Liu X, Zhang W, Xiao W. p53 directly suppresses BNIP3 expression to protect against hypoxia-induced cell death. EMBO J 2011; 30:3397 - 415; http://dx.doi.org/10.1038/emboj.2011.248; PMID: 21792176
   PubMed Web of Science ®Google Scholar
• Rho SB, Lee JH, Park MS, Byun HJ, Kang S, Seo SS, et al. Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53. FEBS Lett 2011; 585:29 - 35; http://dx.doi.org/10.1016/j.febslet.2010.11.014; PMID: 21081126
   PubMed Web of Science ®Google Scholar
• Amson R, Pece S, Lespagnol A, Vyas R, Mazzarol G, Tosoni D, et al. Reciprocal repression between P53 and TCTP. Nat Med 2012; 18:91 - 9; http://dx.doi.org/10.1038/nm.2546; PMID: 22157679
   PubMed Web of Science ®Google Scholar
• Sun Y, Yi H, Zhang PF, Li MY, Li C, Li F, et al. Identification of differential proteins in nasopharyngeal carcinoma cells with p53 silence by proteome analysis. FEBS Lett 2007; 581:131 - 9; http://dx.doi.org/10.1016/j.febslet.2006.12.008; PMID: 17184779
   PubMed Web of Science ®Google Scholar
• Zheng H, Whitman SA, Wu W, Wondrak GT, Wong PK, Fang D, et al. Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy. Diabetes 2011; 60:3055 - 66; http://dx.doi.org/10.2337/db11-0807; PMID: 22025779
   PubMed Web of Science ®Google Scholar